A $10,000 position in the Defiance Quantum ETF (NYSEARCA:QTUM) on the last trading day of 2025 was worth about $15,420 by the close on June 2, 2026, a 54.2% year-to-date move from a starting price of $109.44 to $168.76. Over the same stretch the S&P 500, as proxied by SPY, returned 11%, and the Nasdaq-100 via QQQ, the closest thing to a clean Magnificent 7 wrapper, returned 21%. A theme ETF beating the broad market by a factor of nearly five in five months is the kind of number that sends people to Google, and that is what you are doing here.
QTUM is a straightforward thematic vehicle. It tracks the BlueStar Quantum Computing and Machine Learning Index, holds roughly 70 to 80 names on an equal-weighted basis, charges a 0.40% expense ratio, and has been trading since September 2018. The $23.21 launch-window price sits well in the rear-view mirror, with the fund up 627% since inception and 99% in the trailing year alone. The 2026 surge is therefore the second leg of a move that was already running.
What actually did the work
Equal weighting matters here, because it means the run is not the product of one or two names dragging an index higher in a Mag 7-style top-heavy way. The run is the product of the bench, with the equal-weighted structure preventing any one or two names from dragging the index higher Mag 7 style. That said, the pure-play quantum names inside QTUM have done staggering fundamental work this year, and they are the easiest place to start.
IonQ (NYSE:IONQ | IONQ Price Prediction) reported Q1 2026 revenue of $64.67 million, growth of 755% year over year, and the company raised full-year guidance to $260 million to $270 million while telling the Street to expect adjusted EBITDA losses of ($330) million to ($310) million. Remaining performance obligations stood at $470 million, up 554% year over year. CEO Niccolo de Masi described it as "our fourth consecutive quarter of record-breaking results and the biggest quarter in our company’s history". The stock is up 59% YTD and 55% in the last month alone.
Rigetti Computing (NASDAQ:RGTI) is the smaller, noisier sibling. Q1 revenue came in at $4.4 million against $1.47 million a year earlier, nearly a triple, and the company is sitting on $569 million in cash and investments with no debt. The 108-qubit Cepheus-1-108Q is now generally available on Rigetti QCS, Amazon Braket, Microsoft Azure Quantum, and qBraid, with median two-qubit gate fidelity of 99.8% and prototype results as high as 99.9%. CEO Subodh Kulkarni called Cepheus-1-108Q "one of the most powerful generally available gate-based quantum computers in the world". The stock is up 21% YTD but more than doubled over the trailing year at 119%.
The fundamentals are real, with the usual caveat that real means "triple-digit growth off a tiny base." IonQ is still posting an adjusted EBITDA loss of ($97) million per quarter and burned $151 million in operating cash. Rigetti’s GAAP net income of $33 million is almost entirely a $54 million non-cash swing in derivative warrant liabilities, not a business turning a profit. These are venture-style stories trading inside a public-market wrapper. The mechanism that lifted QTUM is partly that the wrapper itself, an equal-weighted basket, lets you ride the theme without picking which trapped-ion or superconducting bet survives.
The bench, the chips, and the AI overlap
The other engine is the "and Machine Learning" half of the index name. QTUM owns a long tail of semiconductor, networking, and cloud-infrastructure names that have benefited from the same AI capex wave powering the Magnificent 7. Goldman Sachs noted in its 2026 outlook that the AI capex boom has become the dominant business and investment engine in the US economy, with growth based on "long-term transformative investments potentially masking the true nature of the underlying real economy." Vanguard framed 2026 as the year AI gets "embedded in workflows" with a possible compute-paradigm shift if the "hoped-for quantum leap in AI capability remains elusive." That is the macro tailwind sitting under the basket.
So you have two stacked tailwinds inside one fund. Pure-play quantum names compounding from microscopic revenue bases at triple-digit growth rates, and AI-adjacent semis and cloud platforms riding the same capex story that has lifted QQQ 21% YTD. Equal weighting then amplifies the quantum half. In a market-cap-weighted theme fund, a name like Rigetti at an $8.93 billion market cap would be a rounding error next to NVIDIA. In QTUM, it gets the same slot as the largest holdings on every rebalance. That is the structural reason the ETF outran the Mag 7 in 2026 even though the Mag 7 itself had a fine year.
Real progress or sentiment
Both, and the proportions matter. The revenue numbers at IonQ are verifiable filings. About 60% of revenue is commercial and 35% international, and the company shipped its first 256-qubit system to the University of Cambridge along with DARPA, Space Development Agency, and Missile Defense Agency contracts. Government and defense buyers writing real checks for real hardware is a different signal than press-release qubit counts.
What is harder to defend is valuation. IonQ carries a market cap of roughly $26.65 billion against full-year revenue guidance topping out at $270 million, which works out to a price-to-sales ratio in the high double digits even on the optimistic line. Rigetti is at $8.93 billion on $4.4 million of quarterly revenue, which is a sentence that does not require commentary. One AI-focused podcast guest captured the mood when discussing the sector last cycle, noting that two of the quantum names "have like 7 billion in equity value between them and they have like less than 10 million in trailing revenue" and calling it a "total bubble." The valuations have only stretched since.
Polymarket, for what it is worth, has a market on whether the US federal government will take a stake in IonQ resolving by year-end, with Yes priced at 44% and No at 56%. That is the kind of question that exists in a sentiment regime, not in a sober one.
What to watch from here
The forward case for QTUM has three legs, and you can monitor each of them without a Bloomberg terminal.
First, watch IonQ’s revenue cadence against the Q2 guide of $65 million to $68 million and the full-year $260 million to $270 million bar. The basket re-rated this year because IonQ delivered a 30% beat on Q1 guidance midpoint. A clean in-line report would still be acceptable. A miss would tell you the growth curve is bending, and at these multiples that matters more than direction.
Second, watch the AI capex line. The leading indicators are the hyperscaler capex commitments each quarter and the bond-issuance pace from AI-oriented names, which Goldman flagged as having become more active in the 2025 corporate bond market. QTUM’s quantum-adjacent half rides that wave. If capex guidance starts coming down, the chip and cloud bench inside the fund stops contributing and the burden falls entirely on a small pile of pre-revenue quantum names that cannot carry it alone.
Third, watch fidelity benchmarks and customer announcements rather than qubit-count headlines. 99.8% median two-qubit gate fidelity on a generally available 108-qubit system is the kind of number that determines whether quantum advances from a science project to something a pharmaceutical company will pay seven figures to access. That is the real fundamental dial.
The honest read is that QTUM’s 2026 is a regime trade riding two tailwinds at once, and the trade worked because the equal-weighted structure let a handful of small, fast-growing pure-plays do disproportionate work alongside an AI-adjacent bench. The mechanism is intact today. It is also expensive today. A QTUM bought at $168.76 is a different security than one bought at $109.44 on January 2, even with the same ticker and the same prospectus. The number to remember is the gap between QTUM’s 54% and SPY’s 11%. Gaps that wide rarely repeat from the new starting line, and the question for the next five months is whether the IonQ guide for Q2 lands above $68 million.
Top Gaining Stocks
Top Losing Stocks